SCHEMBL31717080

SCHEMBL31717080

COc1cc2c(=O)[nH]c(Cc3ccc(-c4cc(F)cc(F)c4)nc3)nc2cc1NS(C)(=O)=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.40
▸ KDM4E B2RXH2 3/20 0.39
▸ GAA P10253 1/20 0.39
▸ KIT P10721 1/20 0.38
▸ ALDH1A1 P00352 4/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ NR3C1 P04150 1/20 0.36
▸ PGR P06401 1/20 0.36
▸ NR3C2 P08235 1/20 0.36
▸ AR P10275 1/20 0.36
▸ ROCK2 O75116 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ CYP11B1 P15538 1/20 0.36
▸ CYP11B2 P19099 1/20 0.36
▸ PDE10A Q9Y233 1/20 0.36
▸ PARP14 Q460N5 1/20 0.36
▸ THRB P10828 1/20 0.35
▸ CASP1 P29466 1/20 0.35
▸ HBB P68871 1/20 0.35
▸ USP2 O75604 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31716955 0.88 LMNA (0.43) LMNAKDM4EGAAALDH1A1MAPK1
SCHEMBL31715980 0.87 LMNA (0.42) LMNAKDM4EGAAALDH1A1MAPK1
SCHEMBL31716099 0.86 LMNA (0.41) LMNAKDM4EGAAALDH1A1MAPK1
SCHEMBL31716946 0.85 LMNA (0.44) LMNAKDM4EGAAALDH1A1MAPK1
SCHEMBL31717042 0.84 LMNA (0.43) LMNAKDM4EGAAALDH1A1MAPK1
SCHEMBL31716882 0.84 MAPK1 (0.46) LMNAKDM4EGAAALDH1A1MAPK1
SCHEMBL31716050 0.83 LMNA (0.43) LMNAKDM4EGAAALDH1A1MAPK1
Hydrochloric Acid SCHEMBL31716036 0.81 LMNA (0.41) LMNAROCK2
SCHEMBL31715994 0.81 KDM4E (0.46) LMNAKDM4EGAAALDH1A1MAPK1
SCHEMBL31715978 0.80 LMNA (0.48) LMNAKDM4EGAAALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025227032-A1 METHODS FOR DEGRADATION OF CYCLIN K AND INHIBITION OF CYCLIN DEPENDENT KINASES REMIX THERAPEUTICS INC. (US) 2025-10-30 — — WO disclosed
Send feedback